BTIG Reiterates Sell on Ginkgo Bioworks Holdings, Maintains $5 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.7%

Neg 0% Neu 88.7% Pos 0%

BTIG analyst Mark Massaro reiterates Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and maintains $5 price target.

Comments

No comments yet. Be the first!